These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34738993)

  • 1. The association between the Moyamoya disease susceptible gene RNF213 variant and incident cardiovascular disease in a general population: the Nagahama study.
    Tabara Y; Yamada H; Setoh K; Matsukawa M; Takahashi M; Kawaguchi T; Nakayama T; Matsuda F; Kosugi S
    J Hypertens; 2021 Dec; 39(12):2521-2526. PubMed ID: 34738993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
    Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
    Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.
    Liu W; Morito D; Takashima S; Mineharu Y; Kobayashi H; Hitomi T; Hashikata H; Matsuura N; Yamazaki S; Toyoda A; Kikuta K; Takagi Y; Harada KH; Fujiyama A; Herzig R; Krischek B; Zou L; Kim JE; Kitakaze M; Miyamoto S; Nagata K; Hashimoto N; Koizumi A
    PLoS One; 2011; 6(7):e22542. PubMed ID: 21799892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant association of RNF213 p.R4810K, a moyamoya susceptibility variant, with coronary artery disease.
    Morimoto T; Mineharu Y; Ono K; Nakatochi M; Ichihara S; Kabata R; Takagi Y; Cao Y; Zhao L; Kobayashi H; Harada KH; Takenaka K; Funaki T; Yokota M; Matsubara T; Yamamoto K; Izawa H; Kimura T; Miyamoto S; Koizumi A
    PLoS One; 2017; 12(4):e0175649. PubMed ID: 28414759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variant RNF213 c.14576G>A in various phenotypes of intracranial major artery stenosis/occlusion.
    Miyawaki S; Imai H; Shimizu M; Yagi S; Ono H; Mukasa A; Nakatomi H; Shimizu T; Saito N
    Stroke; 2013 Oct; 44(10):2894-7. PubMed ID: 23970789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations.
    Liu W; Hitomi T; Kobayashi H; Harada KH; Koizumi A
    Neurol Med Chir (Tokyo); 2012; 52(5):299-303. PubMed ID: 22688066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new horizon of moyamoya disease and associated health risks explored through RNF213.
    Koizumi A; Kobayashi H; Hitomi T; Harada KH; Habu T; Youssefian S
    Environ Health Prev Med; 2016 Mar; 21(2):55-70. PubMed ID: 26662949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF213 p.R4810K Variant Carriers with Intracranial Arterial Stenosis Have a Low Atherosclerotic Burden.
    Ohara M; Yoshimoto T; Okazaki S; Gon Y; Todo K; Sasaki T; Takasugi J; Ohara N; Ihara M; Mochizuki H
    J Atheroscler Thromb; 2022 Nov; 29(11):1655-1662. PubMed ID: 34955493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of RNF213 4810G>A and 4950G>A Variants in Patients with Moyamoya Disease in Korea.
    Park YS; An HJ; Kim JO; Kim WS; Han IB; Kim OJ; Kim NK; Kim DS
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29160859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of RNF213 variants in symptomatic intracranial arterial stenosis/occlusion in China.
    Sun X; Luo M; Li J; Lai R; Lin J; Wang Y; Xu X; Wu S; Sheng W
    Mol Genet Genomics; 2020 May; 295(3):635-643. PubMed ID: 32020275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of RNF213 rs112735431 Genetic Polymorphism in Non-Cardioembolic Ischemic Cerebrovascular Disease: A Cross-Sectional Study in Thai Patients.
    Travanichakul S; Chutinet A; Kijpaisalratana N; Snabboon T; Houngngam N; Suwanwela NC
    Cerebrovasc Dis Extra; 2024; 14(1):118-124. PubMed ID: 39159618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An analysis of the demographic history of the risk allele R4810K in RNF213 of moyamoya disease.
    Koganebuchi K; Sato K; Fujii K; Kumabe T; Haneji K; Toma T; Ishida H; Joh K; Soejima H; Mano S; Ogawa M; Oota H
    Ann Hum Genet; 2021 Sep; 85(5):166-177. PubMed ID: 34013582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.
    Koizumi A; Kobayashi H; Liu W; Fujii Y; Senevirathna ST; Nanayakkara S; Okuda H; Hitomi T; Harada KH; Takenaka K; Watanabe T; Shimbo S
    Environ Health Prev Med; 2013 Mar; 18(2):121-9. PubMed ID: 22878964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
    Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
    Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.